Latest News

Saturday, May 28, 2016 | Miscellaneous

Internationally Acclaimed Ophthalmologist and Former ESCRS President Peter Barry Dies

Peter Barry, FRCS, head of the Department of Ophthalmology in St Vincent’s University Hospital, Dublin, died on Thursday after a short illness. In a statement, the European Society of Catarac…

Read the full story

Friday, May 27, 2016 | Medical Studies, Can-Fite BioPharma

Can-Fite Reports Provides Clinical Pipeline Update

Can-Fite BioPharma reported financial results for the three months ended March 31, 2016 and updates on its drug development programs. CF101 -- Phase 2 Glaucoma Results Expected in June; Phas…

Read the full story

Friday, May 27, 2016 | Medical Studies

ADHD: Do the Eyes Have It?

Examining the retina may aid in the diagnosis of attention-deficit/hyperactivity disorder (ADHD), new research shows. Confirming prior work, researchers observed that patients with untreated ADHD have…

Read the full story

Friday, May 27, 2016 | Acquisitions/Mergers, Valeant

Valeant Said to Have Rejected a Takeover Bid This Spring

Valeant Pharmaceuticals International received a joint takeover offer from Japan’s Takeda Pharmaceutical and TPG Capital Management this spring that the Canadian drugmaker rejected, according to…

Read the full story

Thursday, May 26, 2016 | Product Releases, MORIA

Moria Releases Single-Use Donor Vacuum Guarded Punches

Moria has extended its portfolio in endothelial graft preparation by releasing its single-use donor vacuum guarded punches. The punches safely assist corneal surgeons and/or eye bank practitioners in …

Read the full story

Thursday, May 26, 2016 | Awards, Regeneron Pharmaceuticals

Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search

Society for Science & the Public announced that Regeneron Pharmaceuticals is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from …

Read the full story

Thursday, May 26, 2016 | Medical Studies

Rapid Growth of E-commerce Predicted to Boost the Global Contact Lens Market Through 2020, Says Technavio

According to the latest research study released by Technavio, the global contact lens market is expected to grow at a CAGR of over 6% until 2020. The research report, titled ‘Global Contact Lens…

Read the full story

Thursday, May 26, 2016 | Conferences

5 Key Ophthalmology Takeaways: American Society of Cataract and Refractive Surgery (ASCRS) 2016

In early May, the American Society of Cataract and Refractive Surgery (ASCRS) held its annual symposium in New Orleans. As usual, the meeting was packed with new technologies and interesting studies t…

Read the full story

Thursday, May 26, 2016 | Clinical Trials, Acucela

Phase 2b/3 Clinical Trial of Acucela's Emixustat Does Not Meet Primary Endpoint

Acucela announced top-line results from the phase 2b/3 clinical trial (SEATTLE study) of the investigational visual cycle modulator emixustat hydrochloride (emixustat), according to a company news rel…

Read the full story

Wednesday, May 25, 2016 | Management/Leadership, Alphaeon

Robert Grant No Longer CEO of Alphaeon

Robert Grant is no longer CEO of Alphaeon, Eyewiretoday.com has learned. After 3 years at the helm of the lifestyle health care company, Mr. Grant is relinquishing the leadership role of the company h…

Read the full story

Wednesday, May 25, 2016 | Retina, Regeneron Pharmaceuticals

Regeneron Announces US Prescribing Information Clarification for Eylea Injection

Regeneron Pharmaceuticals announced that the FDA has approved an update to the dosage and administration section of the Eylea (aflibercept) Injection US Prescribing Information for patients with neova…

Read the full story

Wednesday, May 25, 2016 | Medical Studies, American Academy of Ophthalmology

Zika Virus May Be Linked to More Eye Problems in Brazilian Babies with Microcephaly

Researchers studying babies with a Zika virus-related birth defect say they have found previously unreported eye problems possibly linked to the virus that could result in severe visual impairment, ac…

Read the full story

Tuesday, May 24, 2016 | Management/Leadership

Visiometrics Appoints New Vice President

Ophthalmic diagnostic instrument maker Visiometrics has appointed Nick Levandowsky Vice President, Global Marketing and North America Sales, according to a company news release. In his new role, Mr…

Read the full story

Tuesday, May 24, 2016 | Miscellaneous, Bausch+Lomb, Valeant

Valeant CEO Papa Calls B&L Division a 'Core Franchise'

Valeant Pharmaceuticals International Inc. would contemplate selling off some assets but sees Bausch & Lomb Inc.’s ophthalmic division as a “core franchise” it should hang on to,…

Read the full story

Tuesday, May 24, 2016 | Clinical Trials, Alimera Sciences

Majority of Chronic DME Patients Gain or Maintain Vision with Single Iluvien Injection Injection at 12 Months

Two real world data sources, revealed at the Royal College of Ophthalmologists (RCOphth) Annual Congress, show that the majority of chronic diabetic macular edema (DME) patients who received a single …

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $17.14  0.00% 
 Akorn, Inc. $30.16  0.00% 
 Alimera Sciences, Inc. $1.55  0.00% 
 Allergan $235.94  0.00% 
 Avalanche Biotechnologies $4.14  0.00% 
 Bayer $95.22  0.00% 
 Can-Fite Biopharma $2.79  0.00% 
 Carl Zeiss Meditec $34.76  0.72% 
 Cooper Companies, Inc. $162.50  0.00% 
 Eleven Biotherapeutics $1.32  0.00% 
 Escalon Medical Corp. $0.85  0.00% 
 Essilor International $128.75  0.00% 
 Glaukos $24.36  0.00% 
 Imprimis Pharmaceuticals, Inc. $4.01  0.00% 
 Inotek Pharmaceuticals $9.00  0.00% 
 InSite Vision, Inc. $0.35  0.00% 
 IRIDEX Corporation $14.05  0.00% 
 Johnson & Johnson $113.06  0.00% 
 Luxottica Group, S.p.A. $54.60  0.00% 
 Merck & Company, Inc. $56.48  0.00% 
 NicOx $10.95  -0.50% 
 NovaBay Pharmaceuticals, Inc. $2.84  0.00% 
 Novartis AG Common Stock $80.11  0.00% 
 Ocular Therapeutix $11.93  0.00% 
 Ophthotech Corporation $51.14  0.00% 
 QLT $1.49  0.00% 
 Quantel $3.78  5.00% 
 Regeneron $396.22  0.00% 
 Roche $33.20  0.00% 
 Second Sight Medical Products $3.82  0.00% 
 Shire $186.96  0.00% 
 STAAR Surgical Company $5.43  0.00% 
 TearLab Corporation $0.76  0.00% 
 Thrombogenics $3.61  0.00% 
 Topcon Corporation $9.98  0.00% 
 TriVascular Technologies, Inc. $5.87  0.00% 
 Valeant Pharmaceuticals $28.42  0.00% 
 Xoma $0.70  0.00%